About
Taysha Gene Therapies Inc (NASDAQ:TSHA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
Mar 19 2026
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 12 2026
Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
Feb 6 2026
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jan 6 2026
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
Financials
Revenue
$9.77 M
Market Cap
$1.33 B
EPS
-0.34
